28-Mar-2024
Benzinga (Thu, 28-Mar 10:25 AM ET)
CVS, Elevance Health to cover Novo Nordisk’s Wegovy: WSJ
Seeking Alpha News (Thu, 28-Mar 10:00 AM ET)
Biden administration issues new ruling against junk health insurance
Seeking Alpha News (Thu, 28-Mar 6:33 AM ET)
Here's How Much $100 Invested In Humana 10 Years Ago Would Be Worth Today
Benzinga (Tue, 26-Mar 2:30 PM ET)
Humana goes ex-dividend tomorrow
Seeking Alpha News (Tue, 26-Mar 10:54 AM ET)
Humana and DUOS Launch Groundbreaking Initiative Enhancing Care for U.S. Veteran Seniors
Business Wire (Wed, 20-Mar 9:10 AM ET)
Humana Completes Aggregate $2.25 Billion Debt Offering
Business Wire (Wed, 13-Mar 5:15 PM ET)
Business Wire (Wed, 13-Mar 4:47 PM ET)
Humana Prices $2.25 Billion Debt Offering
Business Wire (Mon, 11-Mar 8:21 PM ET)
Business Wire (Tue, 5-Mar 10:00 AM ET)
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Humana trades on the NYSE stock market under the symbol HUM.
As of March 28, 2024, HUM stock price declined to $346.72 with 1,471,955 million shares trading.
HUM has a beta of -0.88, meaning it tends to be less sensitive to market movements. HUM has a correlation of 0.11 to the broad based SPY ETF.
HUM has a market cap of $41.83 billion. This is considered a Large Cap stock.
Last quarter Humana reported $26 billion in Revenue and -$.11 earnings per share. This beat revenue expectation by $189 million and missed earnings estimates by -$.06.
In the last 3 years, HUM stock traded as high as $571.30 and as low as $334.54.
The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HUM has underperformed the market in the last year with a price return of -30.7% while the SPY ETF gained +33.6%. HUM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.6% and +0.7%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
HUM support price is $345.07 and resistance is $353.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM stock will trade within this expected range on the day.